|
Family reflections: pediatric aplastic anemia research; a parent perspective |
Oct 2024 |
Pediatric Research |
Aplastic Anemia, Pediatric |
|
Family reflections: George Elliott: a first-person commentary on pediatric aplastic anemia research |
Aug 2024 |
Pediatric Research |
Aplastic Anemia |
|
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria |
Jul 2023 |
Blood Reviews |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials |
May 2024 |
Current Medical Research and Opinion |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria |
Mar 2024 |
Hematology. |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
|
Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
Dec 2023 |
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
|
Existing agents, novel agents, or transplantation for high-risk MDS |
Dec 2020 |
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
|
Excellent Outcomes in Feasibility Study of Radiation-Free Conditioning and Transplant in Pediatric Severe Aplastic Anemia. |
Sep 2025 |
Transplantation and Cellular Therapy |
Aplastic Anemia |
|
Evolving therapies for lower-risk myelodysplastic syndromes |
Apr 2020 |
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality? |
Jun 2020 |
Best practice & research. Clinical haematology |
Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
